
Charles Atkinson
Examiner (ID: 13902)
| Most Active Art Unit | 2306 |
| Art Unit(s) | 2305, 2604, 2307, 2413, 2306, 2313 |
| Total Applications | 1186 |
| Issued Applications | 1116 |
| Pending Applications | 2 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6558068
[patent_doc_number] => 20020194640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Plant promoter derived from luminal binding protein gene and methods for its use'
[patent_app_type] => new
[patent_app_number] => 10/117641
[patent_app_country] => US
[patent_app_date] => 2002-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12988
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20020194640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117641 | Plant promoter derived from luminal binding protein gene and methods for its use | Apr 2, 2002 | Abandoned |
Array
(
[id] => 439437
[patent_doc_number] => 07259136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Compositions and methods for treating peripheral vascular disease'
[patent_app_type] => utility
[patent_app_number] => 10/091258
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7882
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/259/07259136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091258 | Compositions and methods for treating peripheral vascular disease | Mar 4, 2002 | Issued |
Array
(
[id] => 853103
[patent_doc_number] => 07378488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-27
[patent_title] => 'Somatostatin antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/469836
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8069
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/378/07378488.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469836 | Somatostatin antagonists | Mar 4, 2002 | Issued |
Array
(
[id] => 6262457
[patent_doc_number] => 20020188102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Virus derived antimicrobial peptides'
[patent_app_type] => new
[patent_app_number] => 10/079075
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11780
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20020188102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10079075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/079075 | Virus derived antimicrobial peptides | Feb 18, 2002 | Issued |
| 10/067988 | Methods for refolding conformationally constrained peptides | Feb 7, 2002 | Abandoned |
Array
(
[id] => 634277
[patent_doc_number] => 07129334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-31
[patent_title] => 'Synthetic peptide and uses for same'
[patent_app_type] => utility
[patent_app_number] => 10/466193
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2082
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/129/07129334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466193
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466193 | Synthetic peptide and uses for same | Jan 29, 2002 | Issued |
Array
(
[id] => 7616997
[patent_doc_number] => 06946444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-20
[patent_title] => 'Lipoprotein-regulating medicaments'
[patent_app_type] => utility
[patent_app_number] => 10/060845
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 25533
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060845
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060845 | Lipoprotein-regulating medicaments | Jan 28, 2002 | Issued |
| 09/890709 | Methods and compositions for modulating fertility | Jan 27, 2002 | Abandoned |
Array
(
[id] => 7297225
[patent_doc_number] => 20040214777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Peptide activators of VEGF'
[patent_app_type] => new
[patent_app_number] => 10/032361
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9582
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214777.pdf
[firstpage_image] =>[orig_patent_app_number] => 10032361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/032361 | Peptide activators of VEGF | Dec 20, 2001 | Issued |
Array
(
[id] => 5787220
[patent_doc_number] => 20020160476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Nucleic acids and proteins from cenarchaeum symbiosum'
[patent_app_type] => new
[patent_app_number] => 10/027806
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 30104
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10027806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/027806 | Nucleic acids and proteins from cenarchaeum symbiosum | Dec 20, 2001 | Abandoned |
Array
(
[id] => 958828
[patent_doc_number] => 06953774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-11
[patent_title] => 'Methods of inducing ovulation'
[patent_app_type] => utility
[patent_app_number] => 10/014812
[patent_app_country] => US
[patent_app_date] => 2001-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11432
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/953/06953774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014812 | Methods of inducing ovulation | Dec 13, 2001 | Issued |
Array
(
[id] => 6290070
[patent_doc_number] => 20020055145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Purification of human troponin I'
[patent_app_type] => new
[patent_app_number] => 09/998619
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4788
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055145.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998619
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998619 | Purification of human Troponin I | Nov 29, 2001 | Issued |
Array
(
[id] => 6476392
[patent_doc_number] => 20020151703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Process for producing microbial transglutaminase'
[patent_app_type] => new
[patent_app_number] => 09/996561
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6648
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151703.pdf
[firstpage_image] =>[orig_patent_app_number] => 09996561
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/996561 | Process for producing microbial transglutaminase | Nov 29, 2001 | Abandoned |
| 09/979032 | Pharmaceutical preparation containing modifications of surfactant protein b(sp-b) and surfactant protein c (sp-c) | Nov 14, 2001 | Abandoned |
Array
(
[id] => 6760791
[patent_doc_number] => 20030124152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Use of decorin in a cosmetic or dermatologic composition'
[patent_app_type] => new
[patent_app_number] => 10/004176
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9499
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124152.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004176
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004176 | Use of decorin in a cosmetic or dermatologic composition | Nov 1, 2001 | Abandoned |
Array
(
[id] => 7290677
[patent_doc_number] => 20040110662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/415878
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10171
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110662.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415878 | Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors | Oct 31, 2001 | Issued |
Array
(
[id] => 6766090
[patent_doc_number] => 20030100490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans\n'
[patent_app_type] => new
[patent_app_number] => 09/978309
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 44167
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100490.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978309
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978309 | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans | Oct 14, 2001 | Issued |
Array
(
[id] => 6792469
[patent_doc_number] => 20030087813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Cyclosporin analogs for the treatment of lung diseases'
[patent_app_type] => new
[patent_app_number] => 09/975923
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10620
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087813.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975923
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975923 | Cyclosporin analogs for the treatment of lung diseases | Oct 11, 2001 | Abandoned |
Array
(
[id] => 1107907
[patent_doc_number] => 06809077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-26
[patent_title] => 'Cyclosporin analogs for the treatment of autoimmune diseases'
[patent_app_type] => B2
[patent_app_number] => 09/976219
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10671
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/809/06809077.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976219
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976219 | Cyclosporin analogs for the treatment of autoimmune diseases | Oct 11, 2001 | Issued |
Array
(
[id] => 755184
[patent_doc_number] => 07019123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-28
[patent_title] => 'Human bikunin'
[patent_app_type] => utility
[patent_app_number] => 09/974026
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 24
[patent_no_of_words] => 24378
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 270
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/019/07019123.pdf
[firstpage_image] =>[orig_patent_app_number] => 09974026
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/974026 | Human bikunin | Oct 9, 2001 | Issued |